Chinese sportswear retailer Pou Sheng Int'l receives $1.4 bln privatisation offer
[HONG KONG] , Jan 21 (Reuters) - Chinese sportswear retailer Pou Sheng International (Holdings) Ltd has received a proposal from Pou Chen Corp to be taken private that values it at around HK$11 billion (S$1.85billion), it said in a stock exchange filing on Sunday.
Pou Chen Corp has offered Pou Sheng International a cancellation price of HK$2.03 per share, which represents a premium of around 31.82 per cent over Pou Sheng's last closing price.
Pou Sheng International shareholder Yue Yuen Industrial (Holdings) Ltd will sell its 62.41 per cent stake in Pou Sheng to Pou Chen as part of the proposal at the cancellation price for a total of HK$6.8 billion, according to the stock filing. Pou Chen owns 49.99 per cent of Yue Yuen Industrial.
The move follows a similar transaction last April, when a consortium led by private equity firms Hillhouse Capital Group and CDH Investments offered to buy out Hong Kong-listed Belle International Holdings Ltd in a US$6.8 billion deal, as retailers seek new growth from e-commerce channels and tackle competition from online rivals.
The proposal said the sporting goods industry "is experiencing unprecedented changes and challenges" from the rise of online shopping which has changed customers' expectations and increased market competition.
Pou Sheng International would need "significant investments" to transform its business and would have flexibility and more advantageous financing if it were to be taken private, according to the proposal.
The boards of Pou Chen and Pou Sheng believe Pou Sheng's listing status is ineffective in providing a sufficient source of funding for the company's business and growth, the proposal said.
Pou Chen, a leading Taiwanese footwear manufacturer, will not increase the offer price, according to the stock filing.
Citigroup is acting as financial advisor to Pou Chen.
REUTERS
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
HCA beats first-quarter profit estimates on higher patient admissions
US FDA approves Pfizer’s gene therapy for rare bleeding disorder
EU toughens rules on Chinese fashion retailer Shein
Best World under fire from shareholders at AGM over dividends, director salaries
‘Extreme’ climate blamed for world’s worst wine harvest in 62 years
Sheng Siong Q1 net profit up 9.3% on higher revenue